magnolol has been researched along with Cancer of Gallbladder in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, R; Cao, Y; Gao, G; Gu, J; Li, M; Liu, S; Liu, Y; Lu, J; Mu, J; Shu, Y; Wang, X; Wang, Z; Weng, H; Wu, W; Wu, X; Zhang, B; Zhang, F; Zhang, N; Zhu, J | 1 |
1 other study(ies) available for magnolol and Cancer of Gallbladder
| Article | Year |
|---|---|
Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; cdc25 Phosphatases; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; G1 Phase Cell Cycle Checkpoints; Gallbladder Neoplasms; Human Umbilical Vein Endothelial Cells; Humans; Lignans; Medicine, Chinese Traditional; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Nitric Oxide Synthase; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2015 |